Jonathan Berardi

Rutgers, The State University of New Jersey

ORCID: 0000-0003-3415-2056

Also affiliated with Rutgers New Jersey Medical School

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial”.

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial

EClinicalMedicine(2023)10.1016/j.eclinm.2023.102250

N/A

0.587DataRank · unranked

12 citations

Kara W Chew, Mark J Giganti, Michael D. Hughes, Carlee Moser, Mark Main +79 more

Tecovirimat Treatment of People With HIV During the 2022 Mpox Outbreak

Annals of Internal Medicine(2023)10.7326/m22-3132

N/A

0DataRank · unranked

41 citations

Kate Stoeckle, Simian Huang, Jonathan Berardi, Brett Gray, Marshall J. Glesby +2 more